Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 11/20 | 0.60 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | DHODH | Q02127 | 1/20 | 0.39 |
| ▸ | HTR2B | P41595 | 2/20 | 0.37 |
| ▸ | HTR7 | P34969 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31174603 | 1.00 | ALOX5 (0.60) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL5847281 | 0.82 | ALOX5 (0.50) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL234023 | 0.81 | ALOX5 (0.55) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL28350006 | 0.78 | ALOX5 (0.50) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL1867030 | 0.77 | ALOX5 (0.59) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL89676 | 0.77 | ALOX5 (0.59) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL2724592 | 0.77 | ALOX5 (0.59) | ALOX5GAANPSR1DHODHMEN1 | |
| SCHEMBL19971560 | 0.77 | ALOX5 (0.59) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL5320399 | 0.77 | ALOX5 (0.59) | ALOX5GAANPSR1DHODHHTR2B | |
| SCHEMBL1867028 | 0.77 | ALOX5 (0.59) | ALOX5GAANPSR1DHODHHTR2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114300723-B | Aqueous organic flow battery based on mixed energy storage of insoluble phenazine-based negative electrode and soluble phenazine-based negative electrode electrolyte | 常州大学 | 2024-03-15 | — | — | CN | claimed |
| EP-1461339-B1 | SPIROAZACYCLIC COMPOUNDS AS MONOAMINE RECEPTOR MODULATORS | ACADIA PHARM INC (US) | 2010-04-28 | — | — | EP | claimed |
| EP-0733216-B1 | A METHOD AND MATERIAL FOR THE DETECTION OF IONISING RADIATION | BRITISH NUCLEAR FUELS PLC (GB) | 2000-01-19 | — | — | EP | claimed |
| CN-115863673-B | Electrocatalyst for energy storage of aqueous organic flow battery | 常州大学 | 2025-12-23 | — | — | CN | disclosed |
| CN-119330896-A | High-purity 2-hydroxy phenazine and preparation method thereof | 上海交通大学 | 2025-01-21 | — | — | CN | disclosed |
| CN-119118945-A | Polyhydroxy diphenyl ketone compound and preparation method thereof | 张家界久瑞生物科技有限公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024141614-A1 | COMPOSITION COMPRISING AT LEAST N,N-DICARBOXYMETHYLGLUTAMIC ACID, AT LEAST ONE DIRECT DYE, AT LEAST ONE CATIONIC POLYSACCHARIDE, AND AT LEAST ONE NON-CATIONIC POLYSACCHARIDE | L'OREAL (FR) | 2024-07-04 | — | — | WO | disclosed |
| CN-114300723-B | Aqueous organic flow battery based on mixed energy storage of insoluble phenazine-based negative electrode and soluble phenazine-based negative electrode electrolyte | 常州大学 | 2024-03-15 | — | — | CN | disclosed |
| CN-117715610-A | Composition for simultaneously bleaching and dyeing keratin fibers and method for using same | 莱雅公司 | 2024-03-15 | — | — | CN | disclosed |
| US-20240074953-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING THIS COMPOSITION | L'OREAL (FR) | 2024-03-07 | — | — | US | disclosed |
| US-20240058233-A1 | COMPOSITION FOR THE SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBRES AND PROCESS EMPLOYING THIS COMPOSITION | L'OREAL (FR) | 2024-02-22 | — | — | US | disclosed |
| EP-1508570-A1 | NOVEL PHYSIOLGICALLY ACTIVE SUBSTANCES | MERCIAN CORPORATION (JP) | 2005-02-23 | — | — | EP | disclosed |
| EP-1414785-A1 | NOVEL VINYL N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC | NOVO NORDISK A/S (DK) | 2004-05-06 | — | — | EP | disclosed |
| EP-1414806-A1 | NOVEL VINYL N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC | NOVO NORDISK A/S (DK) | 2004-05-06 | — | — | EP | disclosed |
| US-20030109560-A1 | Novel compounds, their preparation and use | HIGH POINT PHARMACEUTICALS, LLC | 2003-06-12 | — | — | US | disclosed |
| US-20030055076-A1 | Novel compounds, their preparation and use | NOVO NORDISK A/S (DK) | 2003-03-20 | — | — | US | disclosed |
| WO-2003011834-A1 | NOVEL VINYL N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC | NOVO NORDISK A/S (DK) | 2003-02-13 | — | — | WO | disclosed |
| WO-2003011814-A1 | NOVEL VINYL N-(2-BENZOYLPHENYL)-L-TYROSINE DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC | NOVO NORDISK A/S (DK) | 2003-02-13 | — | — | WO | disclosed |
| US-20010020345-A1 | Gasoline additive for direct injection gasoline engine | NIPPON MITSUBISHI OIL CORPORATION | 2001-09-13 | — | — | US | disclosed |
| EP-1122295-A1 | GASOLINE ADDITIVE FOR DIRECT-INJECTION GASOLINE ENGINE | Nippon Mitsubishi Oil Corporation (JP) | 2001-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240058233-A1 | COMPOSITION FOR THE SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBRES AND PROCESS EMPLOYING THIS COMPOSITION | KRT18, CRYAB, SPTBN1 | ALOX5 3091/4885GAA 1160/4885NPSR1 4490/4885 |
| US-20030055076-A1 | Novel compounds, their preparation and use | PPARG, PPARA, PPARD | ALOX5 442/4885GAA 1284/4885NPSR1 385/4885 |
| US-20240074953-A1 | COMPOSITION FOR LIGHTENING KERATIN FIBRES AND PROCESS FOR LIGHTENING KERATIN FIBRES USING THIS COMPOSITION | KRT18, CKAP4, MAP1LC3C | ALOX5 2795/4885GAA 2386/4885NPSR1 4542/4885 |
| US-20030109560-A1 | Novel compounds, their preparation and use | PPARG, PPARD, PPARA | ALOX5 493/4885GAA 1002/4885NPSR1 262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.